European regulators cleared Moderna’s first-of-its-kind vaccine as US approval remains uncertain. On Friday, Moderna’s ...

医薬品受託製造のARCALIS（アルカリス、福島県南相馬市）は27日、メッセンジャーRNA（mRNA）の製剤工場を福島県南相馬市に竣工したと発表した。年間3200万回分のmRNA医薬品を製造する能力をもつ。既存の工場などと合わせ、mRNA医薬品の研究 ...

In recent years, mRNA in lipid nanoparticles (mRNA–LNPs) has emerged as a promising strategy for treating numerous conditions ...

Co-infection of influenza virus and SARS-CoV-2 can lead to more severe disease than infection of either alone.

The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be ...

The recommendation from regulators paves the way for the shot’s approval in the European Union at a time the company is ...

European regulators have approved Moderna Inc.’s novel combination flu and Covid shot, handing a victory to the embattled ...

Europe's medicines regulator recommended approval for Moderna's COVID and flu combination vaccine on Friday, putting it on ...

The current reality is one of verified, world-class innovation that positions Uganda as a hub for advanced biotechnology ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended 6 novel medicines for approval at its February 2026 meeting. These now have to be approved by the European Commission ...

The February 2026 meeting of the EMA's Committee for Medicinal Products for Human Use (CHMP) resulted in recommendations for twelve new medicines.¹ These outcomes, which included recommendations for ...

Boehringer Ingelheim has become the second company to get a product approved under the FDA's national priority voucher ...